144 related articles for article (PubMed ID: 6358206)
1. Mammalian tissue trypsin-like enzymes. Comparative reactivities of human skin tryptase, human lung tryptase, and bovine trypsin with peptide 4-nitroanilide and thioester substrates.
Tanaka T; McRae BJ; Cho K; Cook R; Fraki JE; Johnson DA; Powers JC
J Biol Chem; 1983 Nov; 258(22):13552-7. PubMed ID: 6358206
[TBL] [Abstract][Full Text] [Related]
2. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
3. Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates.
Kam CM; McRae BJ; Harper JW; Niemann MA; Volanakis JE; Powers JC
J Biol Chem; 1987 Mar; 262(8):3444-51. PubMed ID: 3546307
[TBL] [Abstract][Full Text] [Related]
4. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
[TBL] [Abstract][Full Text] [Related]
5. Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors.
Powers JC; Tanaka T; Harper JW; Minematsu Y; Barker L; Lincoln D; Crumley KV; Fraki JE; Schechter NM; Lazarus GG
Biochemistry; 1985 Apr; 24(8):2048-58. PubMed ID: 3893542
[TBL] [Abstract][Full Text] [Related]
6. Effects of secondary interactions on the kinetics of peptide and peptide ester hydrolysis by tissue kallikrein and trypsin.
Fiedler F
Eur J Biochem; 1987 Mar; 163(2):303-12. PubMed ID: 3643848
[TBL] [Abstract][Full Text] [Related]
7. Mammalian tissue trypsin-like enzymes: substrate specificity and inhibitory potency of substituted isocoumarin mechanism-based inhibitors, benzamidine derivatives, and arginine fluoroalkyl ketone transition-state inhibitors.
Kam CM; Hernandez MA; Patil GS; Ueda T; Simmons WH; Braganza VJ; Powers JC
Arch Biochem Biophys; 1995 Feb; 316(2):808-14. PubMed ID: 7864637
[TBL] [Abstract][Full Text] [Related]
8. Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin.
Kawabata S; Miura T; Morita T; Kato H; Fujikawa K; Iwanaga S; Takada K; Kimura T; Sakakibara S
Eur J Biochem; 1988 Feb; 172(1):17-25. PubMed ID: 3278905
[TBL] [Abstract][Full Text] [Related]
9. Human pituitary tryptase: molecular forms, NH2-terminal sequence, immunocytochemical localization, and specificity with prohormone and fluorogenic substrates.
Cromlish JA; Seidah NG; Marcinkiewicz M; Hamelin J; Johnson DA; Chrétien M
J Biol Chem; 1987 Jan; 262(3):1363-73. PubMed ID: 3543004
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and kinetic parameters of hydrolysis by trypsin of some acyl-arginyl-p-nitroanilides and peptides containing arginyl-p-nitroanilide.
Juliano MA; Juliano L
Braz J Med Biol Res; 1985; 18(4):435-45. PubMed ID: 3915433
[TBL] [Abstract][Full Text] [Related]
11. Guinea pig lung tryptase. Localisation to mast cells and characterisation of the partially purified enzyme.
McEuen AR; He S; Brander ML; Walls AF
Biochem Pharmacol; 1996 Jul; 52(2):331-40. PubMed ID: 8694858
[TBL] [Abstract][Full Text] [Related]
12. Tryptase from rat skin: purification and properties.
Braganza VJ; Simmons WH
Biochemistry; 1991 May; 30(20):4997-5007. PubMed ID: 2036367
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the substrate-binding site of trypsin by the aid of tripeptidyl-p-nitroanilide substrates.
Pozsgay M; Szabó G; Bajusz S; Simonsson R; Gáspár R; Elödi P
Eur J Biochem; 1981 Apr; 115(3):497-502. PubMed ID: 7238517
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
[TBL] [Abstract][Full Text] [Related]
15. Dog mastocytoma tryptase: affinity purification, characterization, and amino-terminal sequence.
Caughey GH; Viro NF; Ramachandran J; Lazarus SC; Borson DB; Nadel JA
Arch Biochem Biophys; 1987 Nov; 258(2):555-63. PubMed ID: 3118812
[TBL] [Abstract][Full Text] [Related]
16. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer.
Schwartz LB; Bradford TR
J Biol Chem; 1986 Jun; 261(16):7372-9. PubMed ID: 3519608
[TBL] [Abstract][Full Text] [Related]
17. Substrate specificity and inhibitors of a capillary injury-related protease from sheep lung lymph.
Orlowski M; Lesser M; Ayala J; Lasdun A; Kam CM; Powers JC
Arch Biochem Biophys; 1989 Feb; 269(1):125-36. PubMed ID: 2916836
[TBL] [Abstract][Full Text] [Related]
18. Human cytotoxic lymphocyte tryptase. Its purification from granules and the characterization of inhibitor and substrate specificity.
Poe M; Bennett CD; Biddison WE; Blake JT; Norton GP; Rodkey JA; Sigal NH; Turner RV; Wu JK; Zweerink HJ
J Biol Chem; 1988 Sep; 263(26):13215-22. PubMed ID: 3047119
[TBL] [Abstract][Full Text] [Related]
19. p-Nitroanilides of 3-carboxypropionyl-peptides. Their cleavage by elastase, trypsin, and chymotrypsin.
Kasafírek E; Fric P; Slabý J; Malis F
Eur J Biochem; 1976 Oct; 69(1):1-13. PubMed ID: 991849
[TBL] [Abstract][Full Text] [Related]
20. Human skin tryptase: purification, partial characterization and comparison with human lung tryptase.
Harvima IT; Schechter NM; Harvima RJ; Fräki JE
Biochim Biophys Acta; 1988 Nov; 957(1):71-80. PubMed ID: 3140898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
